News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shrivastava Sanjay
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2022 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 8,403 options
@ $6.7, valued at
$56.3k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Exercised 388 restricted stock units
@ $0 |
|
| 02/22/2021 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Granted 5,673 options to buy
@ $8.2, valued at
$46.5k
|
|
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2019 |
4/A
| Shrivastava Sanjay (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Granted 29,183 options to buy
@ $0
Granted 60,000 options
@ $2.57, valued at
$154.2k
|
|
| 11/29/2018 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Granted 29,183 shares
@ $2.57, valued at
$75k
Granted 60,000 options to buy
@ $2.57, valued at
$154.2k
|
|
| 10/12/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|